An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: The A1chieve study
Diabetes Research and Clinical Practice, Issue 3, Volume 94, pages 352 - 363
Received 20 September 2011, Revised 10 October 2011, Accepted 13 October 2011, Published online Nov-2011
a Institute of Cellular Medicine – Diabetes, Newcastle University, Newcastle upon Tyne, UK
b Internal Medicine, Hai Aljamea Hospital, Jeddah, Saudi Arabia
c Endocrine Research Center (Firouzgar), Institute of Endocrinology & Metabolism, Tehran University of Medical Sciences, Tehran, Iran
d Instituto Jalisciense de Investigacion en Diabetes y Obesidad, Guadalajara, Mexico
e Novo Nordisk International Operations A/S, Zürich, Switzerland
f China-Japan Friendship Hospital, Beijing, China
Corresponding author at: Institute of Cellular Medicine – Diabetes, University of Newcastle upon Tyne, Framlington Place, Newcastle upon Tyne NE2 4HH, UK. Tel.: +44 191 222 7154; fax: +44 191 222 0723.
☆ This study was funded by Novo Nordisk.
☆☆ Clinical trial registration: Clinicaltrials.gov, NCT00869908.
© 2011 Elsevier Ireland Ltd, All rights reserved.